Market by Procedure, Type of Infection, Industry Vertical, Product, and Country | Forecast 2021-2028
The
finding of an in-depth research conducted by Triton shows that the North
America surgical site infection control market will progress with a CAGR of
5.53% in terms of revenue over the forecast phase of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries scrutinized in this market are:
• The United States
• Canada
According
to a report published by the Centers for Disease Control and Prevention (CDC)
in 2019, in 2014, around 14.2 million surgical procedures were performed in
inpatient settings in hospitals in the United States in the year 2014. As per
the CDC’s survey to determine the prevalence of healthcare-associated
infections (HAI), in 2015, close to 110,800 surgical site infection (SSI) cases
were detected in patients. The approximate number of surgical site infection
cases in the United States per year is around 160,000 to 300,000. These
infections incur huge costs, ranging from $3.5 billion to $10 billion.
With
the number of surgical procedures being conducted rising continuously, the
incidence of SSIs is also rising. This makes it extremely crucial to prevent
these infections from occurring. The National Healthcare Safety Network (NHSN),
is a web-based surveillance system used by the CDC to track the cases of
surgical site infections. With the help of this network, hospitals, dialysis
centers, and other healthcare facilities can collect and report data about the
infections. These instances show that the US is taking efforts to decrease and
prevent the SSI cases in the country. Such measures are proving beneficial for
the growth of the United States’ surgical site infection control market.
Founded
in 1949 as a paper broking and converting company, Pacon Manufacturing
Corporation developed the first sterilizable paper to be used in wound care
dressings. With the development of this product, the company delved into the
medical marketplace, engaging in flexographic printing. Pacon has developed
products to convert and package sterile towels, dressings, drapes, towels, and
procedural kits for medical procedures. It is headquartered in New Jersey, the
United States.
1.
NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1.
MARKET DEFINITION
2.2.
PORTER’S FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3.
IMPACT OF COVID-19 ON SURGICAL
SITE INFECTION CONTROL MARKET
2.4.
MARKET ATTRACTIVENESS INDEX
2.5.
VENDOR SCORECARD
2.6.
KEY INSIGHTS
2.7.
MARKET DRIVERS
2.7.1. ENACTMENT
OF THE BEST INFECTION PREVENTION AND CONTROL PRACTICES
2.7.2. GROWING
AGING POPULATION
2.8.
MARKET RESTRAINTS
2.8.1. SURGING
USE OF OUTPATIENT PROCEDURES
2.8.2. INCREASED
USAGES OF MEDICAL DISPOSABLE ITEMS
2.9.
MARKET OPPORTUNITIES
2.9.1. RISING
INCIDENCE OF SURGICAL PROCEDURES
2.9.2. SIGNIFICANT
RISE IN THE OCCURRENCE OF COMPLICATIONS FROM HEALTHCARE-ASSOCIATED INFECTIONS
3.
SURGICAL SITE INFECTION
CONTROL MARKET OUTLOOK – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC
SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS
AND GYNECOLOGY
3.5. WOUND
CLOSURE
3.6. PLASTIC
& RECONSTRUCTIVE SURGERY
3.7. THORACIC
SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER
PROCEDURES
4.
SURGICAL SITE INFECTION
CONTROL MARKET OUTLOOK – BY TYPE OF INFECTION
4.1.
SUPERFICIAL INCISIONAL SSI
4.2.
DEEP INCISIONAL SSI
4.3.
ORGAN OR SPACE SSI
5.
SURGICAL SITE INFECTION
CONTROL MARKET OUTLOOK – BY INDUSTRY VERTICAL
5.1.
HOSPITALS
5.2.
AMBULATORY SURGICAL CENTERS
6.
SURGICAL SITE INFECTION
CONTROL MARKET OUTLOOK – BY PRODUCT
6.1. DISINFECTANTS
6.2. MANUAL
REPROCESSORS SOLUTION
6.3. SURGICAL
DRAPES
6.4. SURGICAL
GLOVES
6.5. SKIN
PREPARATION SOLUTION
6.6. SURGICAL
IRRIGATION
6.7. SURGICAL
SCRUBS
6.8. HAIR
CLIPPERS
6.9. MEDICAL
NONWOVENS
6.10. OTHER
PRODUCTS
7.
SURGICAL SITE INFECTION
CONTROL MARKET - NORTH AMERICA
7.1.
COUNTRY ANALYSIS
7.1.1. THE
UNITED STATES
7.1.2. CANADA
8.
COMPANY PROFILES
8.1. SOTERA
HEALTH LLC
8.2. PACON
MANUFACTURING CORPORATION
8.3. STERIS
CORPORATION
8.4. AMERICAN
POLYFILM
8.5. BIOMERIEUX
SA
8.6. STRYKER
CORPORATION
8.7. BELIMED
AG
8.8. GAMA
HEALTHCARE
8.9. BECTON
DICKINSON AND COMPANY (BD)
8.10. 3M
COMPANY
8.11. GETINGE
AB
8.12. JOHNSON
& JOHNSON
8.13. ANSELL
LTD
8.14. KIMBERLY-CLARK
8.15. LAC-MAC
9.
RESEARCH METHODOLOGY &
SCOPE
9.1.
RESEARCH SCOPE &
DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2.
SOURCES OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3.
RESEARCH METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
TABLE
2 VENDOR SCORECARD
TABLE
3 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE
4 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)
TABLE
5 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)
TABLE
6 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE
7 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
2 TYPES OF HEALTHCARE-ASSOCIATED
INFECTIONS
FIGURE
3 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE
4 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE
5 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE
6 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $
MILLION)
FIGURE
7 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)
FIGURE
8 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028
(IN $ MILLION)
FIGURE
9 NORTH AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE
10 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE
11 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)
FIGURE
12 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)
FIGURE
13 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)
FIGURE
14 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE
15 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE
16 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)
FIGURE
17 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE
18 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE
19 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)
FIGURE
20 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE
21 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)
FIGURE
22 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)
FIGURE
23 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE
24 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)
FIGURE
25 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)
FIGURE
26 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)
FIGURE
27 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)
FIGURE
28 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE
29 THE UNITED STATES SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
30 CANADA SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)